These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Schimke immunoosseous dysplasia and management considerations for vascular risks. Beleford DT; Diab M; Qubty WF; Malloy MJ; Long RK; Shieh JT Am J Med Genet A; 2019 Jul; 179(7):1246-1252. PubMed ID: 31039288 [TBL] [Abstract][Full Text] [Related]
26. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia. Collins MK; Peters K; English JC; Rady P; Tyring S; Jedrych J J Cutan Pathol; 2018 Jun; 45(6):465-467. PubMed ID: 29498428 [No Abstract] [Full Text] [Related]
27. Dental abnormalities and preventive oral care in Schimke immuno-osseous dysplasia. Gendronneau M; Kérourédan O; Taque S; Sixou JL; Bonnaure-Mallet M Eur Arch Paediatr Dent; 2014 Jun; 15(3):217-21. PubMed ID: 24327104 [TBL] [Abstract][Full Text] [Related]
28. Membranous nephropathy in Schimke immuno-osseous dysplasia. Ozdemir N; Alpay H; Bereket A; Bereket G; Biyikli N; Aydoğan M; Cakalağoğlu F; Kiliçaslan I; Akpinar I Pediatr Nephrol; 2006 Jun; 21(6):870-2. PubMed ID: 16570201 [TBL] [Abstract][Full Text] [Related]
29. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Boerkoel CF; O'Neill S; André JL; Benke PJ; Bogdanovíć R; Bulla M; Burguet A; Cockfield S; Cordeiro I; Ehrich JH; Fründ S; Geary DF; Ieshima A; Illies F; Joseph MW; Kaitila I; Lama G; Leheup B; Ludman MD; McLeod DR; Medeira A; Milford DV; Ormälä T; Rener-Primec Z; Santava A; Santos HG; Schmidt B; Smith GC; Spranger J; Zupancic N; Weksberg R Eur J Pediatr; 2000; 159(1-2):1-7. PubMed ID: 10653321 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow transplantation in Schimke immuno-osseous dysplasia. Baradaran-Heravi A; Lange J; Asakura Y; Cochat P; Massella L; Boerkoel CF Am J Med Genet A; 2013 Oct; 161A(10):2609-13. PubMed ID: 23950031 [TBL] [Abstract][Full Text] [Related]
31. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Lücke T; Franke D; Clewing JM; Boerkoel CF; Ehrich JH; Das AM; Zivicnjak M Pediatrics; 2006 Aug; 118(2):e400-7. PubMed ID: 16816006 [TBL] [Abstract][Full Text] [Related]
32. Different Phenotypes of Schimke Immuno-Osseous Dysplasia (SIOD) in Two Sisters with the Same Mutation in the SMARCAL1 Gene. Castellano-Martinez A; Acuñas-Soto S; Varga-Martinez R; Rodriguez-Gonzalez M; Mora-Lopez F; Iriarte-Gahete M; Roldan-Cano V Endocr Metab Immune Disord Drug Targets; 2022; 22(8):888-894. PubMed ID: 35209826 [TBL] [Abstract][Full Text] [Related]
33. Schimke immuno-osseous dysplasia. Basiratnia M; Fallahzadeh MH Saudi Med J; 2007 Mar; 28(3):457-60. PubMed ID: 17334480 [TBL] [Abstract][Full Text] [Related]
34. Schimke immunoosseous dysplasia: an ultra-rare disease. a 20-year case series from the tertiary hospital in the Czech Republic. Zieg J; Bezdíčka M; Němčíková M; Balaščáková M; Suková M; Štěrbová K; Vondrák K; Dušek J; Křepelová A Ital J Pediatr; 2023 Jan; 49(1):11. PubMed ID: 36658659 [TBL] [Abstract][Full Text] [Related]
35. Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Lücke T; Marwedel KM; Kanzelmeyer NK; Hori A; Offner G; Kreipe HH; Ehrich JH; Das AM Pediatr Nephrol; 2004 Jun; 19(6):672-5. PubMed ID: 15054643 [TBL] [Abstract][Full Text] [Related]
36. Eltrombopag (thrombopoietin-receptor agonist) and plasmapheresis as rescue therapy of acute post-renal transplant immune thrombocytopenia in a child with Schimke immuno-osseous dysplasia-case report. Grenda R; Jarmużek W; Latoszyńska J; Prokurat S; Rubik J Pediatr Transplant; 2016 Dec; 20(8):1148-1151. PubMed ID: 27671102 [TBL] [Abstract][Full Text] [Related]
37. Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient. Simon AJ; Lev A; Jeison M; Borochowitz ZU; Korn D; Lerenthal Y; Somech R J Clin Immunol; 2014 Jan; 34(1):76-83. PubMed ID: 24197801 [TBL] [Abstract][Full Text] [Related]
38. Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD). Sanyal M; Morimoto M; Baradaran-Heravi A; Choi K; Kambham N; Jensen K; Dutt S; Dionis-Petersen KY; Liu LX; Felix K; Mayfield C; Dekel B; Bokenkamp A; Fryssira H; Guillen-Navarro E; Lama G; Brugnara M; Lücke T; Olney AH; Hunley TE; Polat AI; Yis U; Bogdanovic R; Mitrovic K; Berry S; Najera L; Najafian B; Gentile M; Nur Semerci C; Tsimaratos M; Lewis DB; Boerkoel CF Clin Immunol; 2015 Dec; 161(2):355-65. PubMed ID: 26499378 [TBL] [Abstract][Full Text] [Related]
39. Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia. Morimoto M; Choi K; Boerkoel CF; Cho KS Nucleus; 2016 Nov; 7(6):560-571. PubMed ID: 27813696 [TBL] [Abstract][Full Text] [Related]
40. Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia. Taha D; Boerkoel CF; Balfe JW; Khalifah M; Sloan EA; Barbar M; Haider A; Kanaan H Am J Med Genet A; 2004 Dec; 131(2):194-9. PubMed ID: 15523612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]